Ruby Singhrao
0009-0007-8161-7289
1 paper found
Refreshing results…
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery
Missing publications? Search for publications with a matching author name.